Organoid Science Enters Clinical Trials for Crohn's Disease Treatment

Organoid Science has initiated Phase 1 clinical trials for ATORM-C, an autologous adult stem cell-derived intestinal organoid therapy targeting Crohn's disease treatment. The breakthrough represents a significant milestone in regenerative medicine, offering potential for personalized organ replacement approaches. This advancement could reshape inflammatory bowel disease management strategies.